The virus responsible for a COVID-19 infection enters the body via the nose and mouth, with the lungs the main location harboring the virus. Once COVID-19 has infected the body, the respiratory system is the first area of the body to be directly affected.
During the initial stages of an infection patients will experience symptoms just like any viral infection, including a fever, fatigue, and aches and pains, but respiratory symptoms will remain unclear. However, 3–4 days after the infection has taken hold, patients will begin to cough and periodically feel breathless. Should they undergo an x-ray at this point, some irregularities will be visible, such as white markings on the lungs. These markings are of great concern as they signal a lack of oxygen exchange taking place alongside inflammation which can eventually lead to pneumonia.
Generally, COVID-19 infections are unique in that the lung inflammation occurs in more than one location, usually affecting 3–4 spots and spreading to both lungs. It is therefore essential that proper medicated treatment be administered at the outset, including antiviral drugs, steroids, and other medication that will help restore lung health. Approximately 10% of patients will experience severe pneumonia, with just 1% losing their lives to the virus.